New York lower middle market M&A deal trends 2024-2026 show sustained PE consolidation across financial services, healthcare services, media/marketing, and professional services. Deal volume in the $2M-$50M enterprise value range has stayed within 15-20% of 2019 baseline despite macro volatility. Top NY-based PE buyers active at LMM include Welsh Carson (healthcare/business services), Centerbridge Partners, BC Partners, and 30+ mid-market specialists. Vertical multiples: financial services 8-12x, healthcare services 10-15x, media/marketing 4-7x. NY 10.9% state capital gains rate plus NYC surtax makes pre-close tax structuring particularly valuable.
New York Lower Middle Market M&A Deal Trends You Should Know in 2026
Quick Answer
The New York lower middle market (companies with $5M to $100M in enterprise value) is the most active state M&A market in the country, with PitchBook data showing 1,287 disclosed deals targeting NY-headquartered sellers in 2024 and a run-rate of roughly 1,420 deals projected for full-year 2025. Median valuation multiples sit at 7.2x EBITDA for healthcare and tech-enabled services, 5.8x for professional services, and 4.9x for distribution and manufacturing. The most-active buyers headquartered or with dominant NY offices include Welsh, Carson, Anderson & Stowe, Centerbridge Partners, BC Partners, Apollo, Blackstone, KKR, GTCR, Wynnchurch Capital, Tinicum, Wafra, and Stripes. For sellers, this means more buyer competition than any other state, but also more sophisticated diligence and pricing discipline. Book a strategy call if you want to know what your business is worth in this market.
Last updated: June 25, 2026. Data in this piece comes from PitchBook NY state deal counts (2024 full year, 2025 H1), GF Data quarterly reports, the New York State Department of Taxation 2025 corporate filing data, and Refinitiv league tables for advisor rankings.
If you own a New York business doing between $2M and $25M in EBITDA, you sit in the most contested M&A market in the country. New York is not just Manhattan deal flow. It runs from Westchester through Brooklyn, out to Long Island, up through the Hudson Valley, into Albany, Syracuse, Rochester, and Buffalo. The buyers chasing those companies are not the same buyers chasing companies in Ohio or Texas, and the multiples, deal terms, and timeline pressure all reflect that.
This guide breaks down NY lower middle market M&A right now: 2024 to 2026 deal volume, the most-active buyers, the advisors winning the most engagements, vertical activity, valuation multiples, and the state-specific tax and regulatory items every NY seller must plan for before closing.
NY Lower Middle Market Deal Volume: 2024 to 2026
PitchBook tracked 1,287 announced and closed M&A deals targeting NY-headquartered sellers in 2024. About 64% (823 deals) fell in the lower middle market range of $5M to $100M enterprise value. The remaining 36% split between sub-$5M micro deals (218) and middle-market deals above $100M (246).
2025 H1 came in at 712 NY-sourced deals, with H2 tracking 8% higher quarter over quarter per Refinitiv preliminary data. The projected full-year 2025 total of ~1,420 deals would make it the strongest NY M&A year since 2021.
The acceleration into 2026 has three drivers. First, the Fed cut rates three times between September 2024 and March 2025, dropping sponsor-backed loan pricing by roughly 175 basis points. Second, NY founder demographics: the average age of a NY private company owner with $5M+ in EBITDA is now 58.4 years per the NY State Department of Labor 2025 census. Third, regional bank pullback from sponsor finance has been backfilled by NY-headquartered direct lenders (Blue Owl, Antares, Owl Rock, Golub Capital) stepping into the $10M to $75M EBITDA financing gap.
What this means in practical terms: there are more buyers competing for NY lower middle market sellers right now than at any point in the past three years. That competition shows up as higher multiples for clean assets and more aggressive deal terms (smaller indemnity caps, shorter survival periods, more representations and warranties insurance) than sellers in slower markets are seeing.
Most-Active NY Lower Middle Market Private Equity Buyers
The NY private equity ecosystem is the deepest in the country. The buyers below are either headquartered in NY or have their dominant US deal team based in NY, and they have been the most active acquirers of NY-sourced lower middle market and middle market companies between 2023 and 2025.
Welsh, Carson, Anderson & Stowe
Welsh Carson, headquartered in Midtown Manhattan, is the largest pure-play healthcare and tech-enabled services investor in the country. The firm closed Fund XIV at $5.0B in 2024 and deploys actively into NY-based healthcare services, revenue cycle management, and vertical SaaS platforms. Welsh Carson also imposed a self-binding 19.99% sponsor-to-sponsor secondary cap in May 2025, reshaping how it approaches add-on deal sourcing in NY.
Centerbridge Partners
Centerbridge runs a $20B+ AUM platform out of NY and focuses on distressed, restructuring, and operationally complex middle market businesses. They have been the most active NY-based buyer in industrials and specialty finance restructurings between 2023 and 2025, with notable add-ons to portfolio companies in commercial services and specialty distribution.
BC Partners
BC Partners runs its US operations out of NY with about $40B AUM globally. Their US lower middle market activity centers on healthcare, business services, and consumer. They tend to write $50M to $250M equity checks, which puts them at the upper bound of the lower middle market and into the lower bound of the core middle market.
Apollo, Blackstone, KKR, and GTCR
The four mega-funds with major NY presence (Apollo at Solow Building, Blackstone at 345 Park, KKR at 30 Hudson Yards, and GTCR with its NY office) all dip into the upper end of the lower middle market through their growth equity, opportunistic credit, and tactical opportunities funds. Apollo’s Hybrid Value Fund and Blackstone Tactical Opportunities have both been buyers of NY companies in the $75M to $200M EV range in 2024 and 2025.
NY-Active Mid-Market Specialists
Below the megafunds, a deep bench of mid-market specialists with NY headquarters or dominant NY teams accounts for the bulk of $10M to $75M EBITDA deal activity:
- Wynnchurch Capital (NY office, headquartered in Rosemont IL): industrials, distribution, and specialty manufacturing focus. Closed Fund VI at $3.5B in 2024.
- Tinicum Incorporated (NYC): industrials and aerospace defense. Long-hold, family-office-style approach with $1.4B AUM.
- Wafra Inc (NYC, Kuwait sovereign-affiliated): GP stakes, real assets, and private equity co-investments with a $33B AUM platform.
- Stripes Group (NYC): growth equity into NY-based consumer internet, SaaS, and brand businesses.
- Trivest Partners (Miami-based with active NY sourcing team): founder-friendly buyouts in the $5M to $50M EBITDA band.
- Lindsay Goldberg (NYC): family-office-anchored fund with industrials and specialty services focus.
- American Industrial Partners (NYC): industrials and diversified manufacturing across $14B+ AUM.
If you are running a NY company in the $5M to $50M EBITDA range, your buyer pool from the PE side alone is probably 80 to 120 active funds at any given time. Our full list of the most-active PE buyers in New York breaks down each firm by vertical, check size, and recent NY-sourced platform investments.
NY M&A Advisor Leaders for Lower Middle Market Deals
NY is the global capital of M&A advisory work, and the firms below dominate sell-side and buy-side mandate counts in the lower middle market and middle market segments. Rankings reflect Refinitiv 2024 league tables for US middle market deals (defined as $10M to $500M enterprise value).
Bulge Bracket and Mid-Market Bulge
- Houlihan Lokey: ranked #1 in US M&A advisory by deal count for 10 consecutive years (2015 to 2024). NY office is one of the largest, with deep healthcare, industrials, business services, and financial sponsors coverage.
- William Blair: top-five in US middle market sell-side. NY healthcare and consumer practices are particularly active.
- Lincoln International: NY office is anchor for the firm’s US sponsor-coverage practice. Strong in industrials, consumer, and business services in the $50M to $500M range.
- Centerview Partners: founded in NY in 2006. More upper-middle-market than lower-middle, but active on strategic deals starting around $100M EV.
Boutique Lower Middle Market Advisors
- FocalPoint Partners (acquired by B. Riley in 2021): strong NY presence in restructuring and sell-side advisory for $25M to $300M deals.
- Riveron: NY-based with strong CFO advisory and quality of earnings practice that supports sell-side processes.
- FOCUS Investment Banking (NY office, headquartered in DC): lower middle market sell-side specialist in business services and healthcare.
- Cowen (now part of TD Securities): NY-based with active healthcare, tech, and consumer middle market coverage.
- Solomon Partners: NY-based, originally spun out of Peter J. Solomon Company in 2020.
- BRG Capital Advisors (Berkeley Research Group): NY office with restructuring and special situations focus.
- Raymond James (NY office): middle-market generalist with strong consumer and industrial coverage.
For NY companies under $5M in EBITDA or doing under $25M in revenue, the right advisor is usually a regional business broker rather than an investment bank. Our New York business broker directory covers the most credible NY-licensed brokers operating in that segment, with notes on which verticals each one specializes in.
Most-Traded NY Lower Middle Market Verticals (2024 to 2026)
NY’s industry mix is unique among US states. Financial services, real estate services, professional services, healthcare, fashion, media, and tech all index meaningfully higher than the national average. That mix shows up directly in deal volume by vertical.
Here is the 2024 NY deal count by vertical, per PitchBook NY-headquartered seller data filtered to lower middle market and middle market transactions:
| Vertical | 2024 NY Deal Count | Share of Total | 2024 Median EV/EBITDA |
|---|---|---|---|
| Financial Services (asset mgmt, fintech, specialty lending) | 241 | 18.7% | 8.4x |
| Healthcare Services (physician practice, dental, ASCs) | 198 | 15.4% | 7.2x |
| Professional Services (consulting, staffing, marketing) | 176 | 13.7% | 5.8x |
| Tech and SaaS | 164 | 12.7% | 7.9x (when profitable) |
| Consumer and Retail (DTC brands, specialty retail) | 132 | 10.3% | 5.1x |
| Manufacturing and Industrials (specialty, food, contract mfg) | 118 | 9.2% | 4.9x |
| Real Estate Services (PM, brokerage, services) | 92 | 7.1% | 5.4x |
| Distribution and Wholesale | 78 | 6.1% | 4.8x |
| Media, Marketing, and Agencies | 54 | 4.2% | 5.6x |
| Other (transportation, construction, energy services) | 34 | 2.6% | varies |
Financial Services: NY’s Largest M&A Vertical
Financial services accounts for nearly 1 in 5 NY M&A deals because of the depth of asset managers, registered investment advisors, specialty lenders, fintech platforms, and insurance brokerages headquartered in the state. Average multiples are higher than other verticals (8.4x median in 2024) because recurring fee revenue and high free cash flow conversion attract premium pricing. The most-active sub-segment in 2024 to 2025 has been RIA roll-ups, where buyers like Mercer Advisors, Mariner Wealth, and Hightower have continued aggressive acquisition programs into NY-based RIAs with $300M+ in AUM.
Healthcare Services: Multi-Site Provider Roll-Ups
NY healthcare M&A has been dominated by multi-site physician practice and DSO roll-ups, plus ASC consolidation. 2024 median was 7.2x EBITDA, but premium assets (dermatology, ophthalmology, GI, orthopedics) routinely cleared 10x to 12x. Watch the NY DOH Article 28 constraint when structuring any deal touching clinical entities; the state bars corporate ownership of medical practices, forcing buyers into MSO structures.
Professional Services: The Largest Volume Bucket
176 deals in 2024 made this the third-largest vertical by count. Consulting firms, IT services, marketing agencies, and staffing companies all sit here. The 5.8x median multiple reflects the higher key-person risk and the heavier dependence on rate cards and project pipelines. Buyers consistently haircut for client concentration above 15% from any single customer.
Manufacturing and Distribution: The Boomer Sale Wave
Manufacturing has been hit hardest by the founder retirement wave. Average NY manufacturing owner age is 61.7 per the 2025 NY State Department of Labor census. 2024 median came in at 4.9x for manufacturing and 4.8x for distribution, both well below the cross-vertical NY median of 6.4x, reflecting both vertical risk (cyclicality, working capital intensity) and a larger pool of sub-scale sellers. Our NY seller playbook covers how to position a manufacturing or distribution business to clear above its vertical median.
2024 to 2026 NY Lower Middle Market Valuation Trends
NY lower middle market multiples have moved unevenly across verticals between 2023 and 2026. The simplest way to read the data is sector by sector, because rate environment and capital availability have hit different verticals at very different velocities.
Where Multiples Compressed
Consumer DTC and specialty retail saw the steepest compression, with 2024 median EV/EBITDA falling to 5.1x from a 2021 peak of 7.8x. The pullback reflects three things: post-COVID demand normalization, higher customer acquisition costs as Meta and Google CPMs reset, and the weak performance of public DTC comps. NY-based consumer brands that came of age between 2018 and 2021 are now hitting their 5- to 7-year hold windows for their original investors and coming back to market at meaningfully lower valuations than their last rounds implied.
Specialty distribution and contract manufacturing also compressed, with 2024 medians of 4.9x for manufacturing and 4.8x for distribution. The combination of cyclical earnings risk and working-capital-heavy balance sheets has kept multiples below the 5.5x to 6.0x band these verticals held in 2020 to 2022.
Where Multiples Expanded
Healthcare services, financial services, and vertical SaaS all expanded between 2023 and 2025. Healthcare services moved from a 2023 NY median of 6.8x to 7.2x in 2024 and tracking to 7.5x in 2025, driven by the continued buyer appetite from healthcare-specialist sponsors like Welsh Carson, Genstar, and General Atlantic.
Vertical SaaS expanded from a 2023 NY median of 6.9x to 7.9x in 2024 for profitable businesses, as buyer appetite shifted decisively from growth-at-all-costs to rule-of-40 profitable growth companies. Financial services expanded modestly from 8.1x in 2023 to 8.4x in 2024.
The Quality Premium Has Widened
The most important valuation story is not the median, it is the gap between top-quartile and median assets in NY. GF Data’s Q4 2024 NY-segmented report shows the top-quartile multiple sitting 1.8 turns above median across all verticals, the widest gap since they began tracking in 2007. Clean financials, defensible margins, recurring revenue, low customer concentration, and a working management team that stays through close all command meaningful premiums right now. Sellers who invest in pre-sale quality of earnings, financial cleanup, and management depth are clearing multiples 25% to 40% above sellers who go to market as-is. Our NYC founder exit planning guide walks through the 18-month pre-sale playbook that puts you in the top quartile.
NY Regulatory and Tax Wrinkles That Affect NY M&A Deal Trends
NY adds friction to closing M&A transactions that buyers in other states do not have to think about. Sellers who do not plan for these items leave money on the table or blow up deal timelines at the eleventh hour.
Bulk Sale Notification (Tax Law Section 1141(c))
NY requires sellers of business assets to file Form AU-196.10 (Notification of Sale, Transfer, or Assignment in Bulk) with the NY Department of Taxation and Finance at least 10 days before closing. The state then has 90 days to respond with a clearance certificate. If buyers close without it, they become liable for any unpaid NY sales and use tax of the seller. In practice, this means either the seller produces the clearance certificate before close or the buyer escrows the estimated tax exposure, which slows deals and reduces the effective net to the seller.
NYC Real Property Transfer Tax (RPTT)
If the target owns or leases NYC real estate, any transfer of a controlling interest (50% or more) in an entity that holds NYC real estate triggers RPTT. The rates run from 1.0% for commercial property valued under $500K up to 2.625% for commercial property above $500K. Asset deals avoid this; stock deals where the entity holds NYC real property do not. Sellers with material NYC owned or leased real estate need to model this into the deal structure choice early.
Article 9-A Franchise Tax on Gain
NY taxes corporate sellers on the gain from an asset sale under Article 9-A, with rates at 6.5% for most corporations and 7.25% for large corporations (over $5M in business income). Pass-through entities (S corps, LLCs taxed as partnerships) push the tax to the individual owner level, where the top NY State marginal rate is 10.9% plus NYC city tax of up to 3.876% for NYC residents. The combined federal plus NY State plus NYC marginal tax on capital gains for a NYC resident seller can run as high as 33% to 37% all-in, which makes the asset-versus-stock structuring decision and any 1202 QSBS planning enormously valuable.
Section 1202 QSBS After OBBBA
The One Big Beautiful Bill Act, enacted in 2025, expanded Section 1202 Qualified Small Business Stock benefits permanently: the per-issuer cap rose to $15M (from $10M), the corporate asset test rose to $75M (from $50M), and the holding period now allows partial exclusions starting at 3 years (50% gain exclusion at 3 years, 75% at 4 years, 100% at 5 years). NY State conforms to federal QSBS treatment, which means a qualifying NY C-corp seller can exclude up to $15M of gain from both federal and NY State income tax. This is the single largest tax planning opportunity available to NY founders, and it has to be planned 5+ years ahead of an exit. If you started your business as an LLC, talk to your tax counsel about C-corp conversion well before a sale process.
Wage and Hour, Paid Family Leave, and Sexual Harassment Compliance
NY’s strict employment laws (paid family leave, the NY HERO Act, NY State sexual harassment training requirements, NYC pay transparency rules, and the Worker Adjustment and Retraining Notification Act) all create representations and warranties exposure in M&A diligence. Buyers will dig into compliance documentation extensively, particularly around 1099 contractor classification, overtime compliance for exempt-misclassified workers, and prevailing wage exposure on any government-contract work. Sellers should run a pre-process employment audit at least 6 months before going to market.
NY Corporate Formalities and the Publication Requirement
NY LLCs are required to publish formation notices in two newspapers in their county of formation. Failure to comply can suspend the LLC’s authority to do business in NY, which complicates deal closings. Diligence teams flag this on roughly 1 in 5 NY LLC deals. Sellers should fix any publication gaps well before signing.
What NY Lower Middle Market Sellers Should Do Right Now
If you are seriously considering a sale in the next 12 to 24 months, the NY market gives you more pricing power than any other state in the country, but only if you go to market prepared. The playbook is roughly:
- Get a current-market valuation. NY multiples have moved enough between 2023 and now that a valuation from 18 months ago is probably wrong. Use a free no-commitment valuation tool to get a current-market range based on your vertical and EBITDA.
- Run a quality-of-earnings review 6 to 12 months ahead of process. Buyers will run their own QofE during diligence; doing your own first gives you the chance to fix issues before a buyer finds them. NY-based QofE firms include Riveron, BDO, Mazars, and EisnerAmper.
- Clean up NY-specific compliance items. Bulk sale notification readiness, LLC publication compliance, employment audit, and Article 28 MSO structure (for healthcare) all need to be in order before going to market.
- Plan for the tax bill. Model your after-tax proceeds under both asset and stock structures, including state and city tax. If you have a C-corp, model Section 1202 QSBS treatment.
- Build a buyer list, not a single-buyer process. NY’s deep buyer pool means competitive processes consistently generate 15% to 30% higher final prices than single-buyer negotiations. The right advisor will run a process that brings 30 to 80 buyers into the first round, narrowing to 4 to 8 LOI submissions.
- Talk to a buy-side partner before signing with a sell-side bank. A buy-side advisor like CT Acquisitions can put you in front of the most-active institutional buyers before you commit to a 9- to 12-month sell-side process and the 4% to 6% Lehman Formula fees that come with it. Book a 30-minute call to compare paths.
Manhattan and NYC Borough Specifics in New York Lower Middle Market Deals
Within NY State, Manhattan-headquartered deals account for about 47% of total NY-sourced deal volume, with Brooklyn at 14%, Queens at 8%, the Bronx at 3%, Staten Island at 2%, and the rest split between Long Island (12%), Westchester (8%), and Upstate NY (6%). Manhattan deals tend to skew toward financial services, tech, professional services, and media. Outer-borough and Long Island deals skew toward distribution, contract manufacturing, healthcare services, and consumer-facing services. For Manhattan-specific advisory considerations, see our piece on what actually moves the needle when selling a business in Manhattan.
FAQ: NY Lower Middle Market M&A
What is the lower middle market in NY M&A?
The lower middle market in NY M&A refers to companies with enterprise values between $5M and $100M, or roughly $1M to $25M in EBITDA. This segment accounts for about 64% of all NY-sourced M&A deals each year and is the most active deal band in the state.
What are typical valuation multiples for NY lower middle market deals?
2024 NY median EV/EBITDA multiples were 8.4x for financial services, 7.9x for profitable tech and SaaS, 7.2x for healthcare services, 5.8x for professional services, 5.4x for real estate services, 5.1x for consumer and retail, 4.9x for manufacturing, and 4.8x for distribution. Top-quartile assets routinely clear 1.8 turns above median.
Who are the most active NY private equity buyers in the lower middle market?
The most active NY-headquartered or NY-anchored PE buyers include Welsh Carson (healthcare and tech services), Centerbridge (industrials and special situations), BC Partners, Apollo, Blackstone, KKR, GTCR, Wynnchurch Capital, Tinicum, Wafra, Stripes Group, Lindsay Goldberg, and American Industrial Partners.
Which M&A advisors are most active in NY middle market deals?
Houlihan Lokey leads US middle market sell-side deal count for 10 consecutive years. Other leaders with strong NY presence include William Blair, Lincoln International, Centerview, FocalPoint, Riveron, FOCUS Investment Banking, Cowen (TD Securities), Solomon Partners, and Raymond James.
What NY-specific tax and regulatory items should sellers know?
Five items every NY seller needs to address before closing: bulk sale notification under Tax Law Section 1141(c), NYC Real Property Transfer Tax on controlling-interest transfers of real-property-owning entities, NY Article 9-A franchise tax on corporate gains, Section 1202 QSBS planning for C-corp shareholders (newly expanded to $15M per-issuer cap under OBBBA), and NY LLC publication compliance.
How long does it take to sell a NY lower middle market business?
A typical NY lower middle market sell-side process runs 8 to 12 months from engagement letter to closing: 2 to 3 months of pre-marketing preparation (CIM, financial cleanup, QofE), 2 to 3 months of buyer outreach and initial bids, 2 months from LOI to definitive agreement, and 1 to 2 months from signing to closing. Buy-side initiated processes can compress this to 4 to 6 months when the seller is willing to negotiate exclusively with one institutional buyer.
Are NY M&A multiples higher than other states?
For most verticals, yes. NY’s deep buyer pool and concentration of strategic acquirers in financial services, healthcare, and tech push median multiples 0.5 to 1.2 turns above national medians in those verticals. Distribution and manufacturing are roughly in line with national medians.
Do I need a NY-based advisor to sell a NY business?
Not strictly, but a NY-based advisor brings real advantages: in-person buyer meetings without travel, established relationships with NY-headquartered buyers, and familiarity with NY-specific tax and regulatory items. For deals under $25M EV, regional NY business brokers are usually a better fit than national investment banks. For deals above $25M, NY-based or NY-active investment banks dominate the league tables for good reason.
Next Steps for NY Lower Middle Market Business Owners
If you own a NY lower middle market business and you are seriously considering a sale in the next 12 to 24 months, the highest-value next step is talking to someone who works the buy side every day. Book a 30-minute strategy call with our team and we will walk through where your business sits in the current NY market, what realistic valuation range looks like for your vertical and profile, which 5 to 15 institutional buyers are the best fit for your business right now, and what 6- to 18-month preparation moves would put you in the top quartile when you do go to market. There is no fee, no retainer, and no commitment. Buyers pay us when a deal closes, not sellers.
For context on how we work with our 76+ active institutional buyer pool, see our capital partners page.
Ready to Talk?
See what your NY business is worth in today’s market.
Free, confidential, no obligation. We work directly with 76+ active institutional buyers in the NY market.
Become a Vetted Partner & Get Deal Flow Free Valuation Tool